Background: Restless legs syndrome (RLS) is a disturbing sensorimotor disorder negatively influencing both sleep and psychological functioning. The aim of the present study was to assess RLS patients with respect to locus of control, sleep-related personality traits, quality of life, and sleep as compared to healthy controls. Method: Thirty-eight patients (18 females and 20 males; mean age: 56.06 years) diagnosed with RLS and an age- and gender-matched control group (n = 42) were recruited. Participants completed a series of questionnaires related to locus of control, personality traits, quality of life, and sleep. Results: Compared to healthy controls, RLS patients had a lower internal locus of control, unfavourable sleep-related personality traits such as low self-confidence and higher mental arousal, poorer quality of life, and more depressive symptoms. Sleep was also affected. Multiple regression analyses showed that a low internal and a high external locus of control were predicted by RLS. Conclusions: The pattern of results suggests that RLS is associated with a low locus of control, negative personality traits, and poor quality of life as compared to healthy controls.

1.
Hornyak M, Kopasz M, Berger M, Riemann D, Voderholzer U: Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome. J Clin Psychiatry 2005;66:1139-1145.
2.
Kushida CA: Clinical presentation, diagnosis, and quality of life issues in restless legs syndrome. Am J Med 2007;120:4-12.
3.
Sethi KD: Restless legs syndrome sees the light of day. Lancet Neurol 2008;7:564-565.
4.
Walters AS: Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995;10:634-642.
5.
Allen RP: Finding the dopamine abnormality in RLS: the iron-dopamine connection evaluated in translational research. Sleep Med 2007;8(suppl 1):S17.
6.
Montplaisier J, Nicolas A, Densle R, Gomez-Mancilla B: Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 1999;52:938-943.
7.
Wang J, O'Reilly B, Venkataraman R, Mysliwiec V, Mysliwiec A: Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: a randomized, double-blind, placebo-controlled study. Sleep Med 2009;10:973-975.
8.
Godau J, Klose U, Di Santo A, Schweitzer K, Berg D: Multiregional brain iron deficiency in restless legs syndrome. Mov Disord 2008;23:1184-1187.
9.
Satija P, Ondo WG: Restless legs syndrome: pathophysiology, diagnosis and treatment. CNS Drugs 2008;22:497-518.
10.
Winkelmann JW: Genetics of restless legs syndrome. Curr Neurol Neurosci Rep 2008;8:211-216.
11.
Ferini-Strambi L: RLS-like symptoms: differential diagnosis by history and clinical assessment. Sleep Med 2007;8(suppl 2):S3-S6.
12.
Hening W, Walters AS, Allen RP, Montplaisier J, Myers A, Ferini-Strambi L: Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 2004;5:237-246.
13.
Ulfberg J, Bjorrvatn B, Leissner L, Gyring J, Karlsborg M, Regeur L Skeidsvoll H, Polo O, Partinen M, Nordic RLS Study Group: Comorbidity in restless legs syndrome among a sample of Swedish adult. Sleep Med 2007;8:768-772.
14.
Innes KE, Selfe TK, Agarwal P: Prevalence of restless legs syndrome in North American and Western European populations: a systematic review. Sleep Med 2011;12:623-634.
15.
Picchietti D-L, Allen RP, Walters AS, Davidson JE, Myers A, Ferini-Strambi L: Restless legs syndrome: prevalence and impact in children and adolescents - the Peds REST study. Pediatrics 2007;120:253-266.
16.
Picchietti DL, Stevens HE: Early manifestations of restless legs syndrome in childhood and adolescence. Sleep Med 2008;9:770-781.
17.
Yilmaz K, Kilincaslan A, Aydin N, Kor D: Prevalence and correlates of restless legs syndrome in adolescents. Dev Med Child Neurol 2011;53:40-47.
18.
Walters AS, Silvestri R, Zucconi M, Chandrashekariah R, Konofal E: Review of the possible relationship and hypothetical links between attention deficit hyperactivity disorder (ADHD) and the simple sleep related movement disorders, parasomnias, hypersomnias, and circadian rhythm disorders. J Clin Sleep Med 2008;4:591-600.
19.
Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J, Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health, International Restless Legs Syndrome Study Group: Restless legs syndrome: diagnostic criteria, special considerations and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-119.
20.
Earley CL: Clinical practice. Restless legs syndrome. N Engl J Med 2003;348:2103-2109.
21.
Lee HB, Hening WA, Allen RP, Kalaydjian AE, Earley CJ, Eaton WW, Lyketsos CG: Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci 2008;20:101-105.
22.
Hornyak M, Feige B, Voderholzer U, Philipsen A, Riemann D: Polysomnography findings in patients with restless legs syndrome and in healthy controls: a comparative observational study. Sleep 2007;30:861-865.
23.
Brand S, Lehtinen A, Hatzinger M, Holsboer-Trachsler E: Comparison of sleep EEG profiles of patients suffering from restless legs syndrome, restless legs syndrome and depressive symptoms, and major depressive disorders. Neuropsychobiology 2010;61:41-48.
24.
Winkelman JW, Redline S, Baldwin CM, Resnick HE, Newman AB, Gottlieb DJ: Polysomnographic and health-related quality of life correlates of restless legs syndrome in the Sleep Heart Health Study. Sleep 2009;32:772-778.
25.
Wesström J, Nilsson S, Sundström-Poromaa I, Ulfberg J: Health-related quality of life and restless legs syndrome among women in Sweden. Psychiatry Clin Neurosci 2010;64:574-579.
26.
Happe S, Reese JP, Stiasny-Kolster K, Peglau I, Mayer G, Klotsche J, Giani G, Geraedts M, Trenkwalder C, Dodel R: Assessing health-related quality of life in patients with restless legs syndrome. Sleep Med 2009;10:295-305.
27.
Hornyak M, Grossmann C, Kohnen RM, Schlatterer M, Richter H, Voderholzer U, Riemann D, Berger M: Cognitive behavioural group therapy to improve patients' strategies for coping with restless legs syndrome: a proof-of-concept trial. J Neurol Neurosurg Psychiatry 2008;79:823-825.
28.
Kalaydjian A, Bienvenu OJ, Hening WA, Allen RP, Eaton WW, Lee HB: Restless legs syndrome and the five-factor model of personality: results from a community sample. Sleep Med 2009;10:672-675.
29.
Rotter J: Generalized expectancies for internal versus external control of reinforcements. Psychol Monogr 1966;80:1-28.
30.
Marsh HW, Richards GE: The Rotter Locus of Control Scale: The comparison of alternative response formats and implications for reliability, validity and dimensionality. J Res Pers 1986;20:509-558.
31.
Kanfer FH, Reinecker H, Schmelzer D: Selbstmanagement-Therapie. Berlin, Springer, 2006.
32.
Ackenheil M, Stotz G, Dietz-Bauer R, Vossen A: Mini International Neuropsychiatric Interview. München, Psychiatrische Universitätsklinik, 1999.
33.
Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C, International Restless Legs Syndrome Study Group: Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4:121-132.
34.
Krampen G: FKK; Fragebogen zu Kompetenz- und Kontrollüberzeugungen. Göttingen, Hogrefe, 1991.
35.
Hoffmann RM, Rasch T, Schnieder G, Heyden T: Fragebogen zur Erfassung allgemeiner Persönlichkeitsmerkmale Schlafgestörter (FEPS-I and II). Göttingen, Hogrefe, 1996.
36.
Harvey AG: A cognitive model of insomnia. Behav Res Ther 2002;40:869-894.
37.
Harvey AG: Pre-sleep cognitive activity: a comparison of sleep-onset insomniacs and good sleepers. Br J Clin Psychol 2000;39:275-286.
38.
Brand S, Hatzinger M, Beck J, Holsboer-Trachsler E: Perceived parenting styles, personality traits and sleep patterns in adolescents. J Adolesc 2009;32:1189-1207.
39.
Averbeck M, Leiberich P, Grote-Kusch MT, Olbrich E, Schröder A, Brieger M, Schuhmacher K: SEL; Skalen zur Erfassung der Lebensqualität. Frankfurt am Main, Pearson, 1997.
40.
Hautzinger M, Keller F, Kühner C: Beck Depressionsinventar. Göttingen, Hogrefe, 2006.
41.
Bastien CH, Vallières A, Morin CM: Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001;2:297-307.
42.
Scheffé H: Practical solutions to the Behrens-Fisher problem. J Am Stat Assoc 1970;65:1501-1508.
43.
Welch BL: The generalisation of student's problems when several different population variances are involved. Biometrika 1947;34:28-35.
44.
Cohen J: Statistical Power Analysis for the Behavioural Sciences, ed 2. Hillsdale, Lawrence Erlbaum Associates,1988.
45.
Cohen J: The earth is round (p < 0.05). Am Psychol 1994;49:997-1003.
46.
Ostacoli L, Saini A, Ferini-Strambi L, Castronovo V, Sguazzotti E, Picci RL, Toje M, Gorzegno G, Capogna S, Dongiovanni V, Dogliotti L, Furlan PM, Berruti A: Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy. Qual Life Res 2010;19:531-537.
47.
Gerber M, Brand S, Holsboer-Trachsler E, Pühse U: Fitness and exercise as correlates of sleep complaints: is it all in our minds? Med Sci Sports Exerc 2010;42:893-901.
48.
Pearson VE, Allen RP, Dean T, Gamaldo CE, Lesage SR, Earley CJ: Cognitive deficits associated with restless legs syndrome (RLS). Sleep Med 2006;7:25-30.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.